Bank of America
AKCA

Bank of America’s Akcea Therapeutics Inc AKCA Stock Holding History

Bank of America’s Portfolio AKCA Stock Details AKCA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-17,114
Closed -$310K – 7605
2020
Q3 		$310K Buy
17,114
+4,564
+36% +$64.7K ﹤0.01% 5033
2020
Q2 		$172K Buy
12,550
+2,055
+20% +$31.7K ﹤0.01% 5344
2020
Q1 		$150K Buy
10,495
+956
+10% +$15.7K ﹤0.01% 5276
2019
Q4 		$162K Sell
9,539
-388
-4% -$7.22K ﹤0.01% 5749
2019
Q3 		$153K Sell
9,927
-18,791
-65% -$400K ﹤0.01% 5823
2019
Q2 		$673K Buy
28,718
+21,636
+306% +$534K ﹤0.01% 4860
2019
Q1 		$202K Buy
7,082
+3,740
+112% +$109K ﹤0.01% 5520
2018
Q4 		$100K Sell
3,342
-1,947
-37% -$54.6K ﹤0.01% 5920
2018
Q3 		$185K Sell
5,289
-7,079
-57% -$214K ﹤0.01% 5532
2018
Q2 		$293K Buy
12,368
+5,490
+80% +$131K ﹤0.01% 5206
2018
Q1 		$176K Sell
6,878
-5,118
-43% -$110K ﹤0.01% 5444
2017
Q4 		$208K Sell
11,996
-3,918
-25% -$76.8K ﹤0.01% 5382
2017
Q3 		$440K Buy
+15,914
New +$295K ﹤0.01% 5032

Bank of America's AKCA Position: Q4 2020 in Review

Bank of America sold out of Akcea Therapeutics Inc (AKCA) in Q4 2020, closing a stake of 17,114 shares — an estimated $310K sold.

Bank of America first reported a position in AKCA in Q3 2017 and held it in 13 quarters. The position peaked at $673K in Q2 2019. 0 funds tracked by Wall St. Rank hold AKCA as of Q4 2020.

  • Bank of America reported no remaining Akcea Therapeutics Inc position as of Q4 2020 after selling out during the quarter.
  • Bank of America sold 17,114 Akcea Therapeutics Inc shares in Q4 2020, an estimated $310K.
  • Bank of America first reported a position in Akcea Therapeutics Inc in Q3 2017 and held it in 13 quarters.
  • Bank of America's Akcea Therapeutics Inc position peaked at $673K in Q2 2019.
  • 0 funds tracked by Wall St. Rank held Akcea Therapeutics Inc as of Q4 2020.

Based on Bank of America's 13F filing for Q4 2020, filed 10 Feb 2021.